COLOMBO, MASSIMO GIUSEPPE
COLOMBO, MASSIMO GIUSEPPE
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy
2021 V. Burgio, M. Iavarone, G.G. Di Costanzo, F. Marra, S. Lonardi, E. Tamburini, F. Piscaglia, G. Masi, C. Celsa, F.G. Foschi, M. Silletta, D.C. Amoruso, M. Rimini, M. Bruccoleri, R. Tortora, C. Campani, C. Solda, M.G. Viola, A. Forgione, F. Conti, F. Salani, S. Catanese, C.M. Giacchetto, C. Fulgenzi, C. Coppola, P. Lampertico, A. Pellino, G. Rancatore, G. Cabibbo, F. Ratti, F. Pedica, A. Della Corte, M. Colombo, F. De Cobelli, L. Aldrighetti, S. Cascinu, A. Casadei-Gardini
Digitization in the Market for Entrepreneurial Finance: Innovative Business Models and New Financing Channels
2021 F. Bertoni, S. Bonini, V. Capizzi, M.G. Colombo, S. Manigart
Feasibility and reproducibility of liver and pancreatic stiffness in patients with alcohol-related liver disease
2019 C.B. Conti, N. Weiler, G. Casazza, C. Schrecker, M. Schneider, M.M. Mücke, A. Queck, E. Herrmann, D. Conte, M. Colombo, S. Zeuzem, M. Fraquelli, M. Friedrich-Rust
Multimodality treatment of hepatocellular carcinoma : How field practice complies with international recommendations
2018 A. Sangiovanni, M. Triolo, M. Iavarone, L.V. Forzenigo, A. Nicolini, G. Rossi, V. La Mura, M. Colombo, P. Lampertico
IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients
2018 E. Galmozzi, F. Facchetti, G. Glenda, A. Loglio, M. Vigano', L. Giovanna, M.G. Colombo, P. Lampertico
Harmful and Beneficial Effects of Anti-coagulants in Patients With Cirrhosis and Portal Vein Thrombosis
2018 V. La Mura, S.V.M. Braham, G. Tosetti, F. Branchi, N. Bitto, M. Moia, A.L. Fracanzani, M. Colombo, A. Tripodi, M. Primignani
Management of Biliary Anastomotic Strictures After Liver Transplantation (BASALT Study): a Nationwide Italian Survey
2017 P. Cantù, I. Parzanese, V. Balassone, A. Di Sario, F. Soggiu, G. Lombardi, F. Barbaro, A. Pisani, A. Baldan, G. Cariani, V. Boarino, A. Fasoli, H. Bertani, E. Forti, M. Bulajic, D. Ghinolfi, E. Nadal, A. Cerofolini, L. Barresi, G. Catalano, I. Stroppa, S. Traini, V. Mazzaferro, L. Cipolletta, A. Tringali, G. Costamagna, P. Ravelli, F. Bazzoli, A. Merighi, M. Caterina Parodi, R. Conigliaro, M. Mutignani, M. Zilli, F. Filipponi, A. Fantin, L. Rodella, I. Tarantino, M. Traina, M. Salizzoni, R. Rosa, F. Malinverno, F. Invernizzi, M. Manini, M.F. Donato, M. Colombo, D. Conte, G. Rossi, R. Penagini
The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B
2017 P. George V., I. Ramazan, D. George N., B. Maria, C. Heng, V.B. Florian, C. Jose Luis, S. Vana, G. John, M. Spilios, A. Loglio, S. Spyros, K. Onur, G. Nikolaos, H. Bettina E., L. Maria, D.L.R. Juan, S. Savvoula, K. Anastasia, V. Ioannis, G. Kostantinos, Y. Cihan, B. Thomas, M.G. Colombo, E. Rafael, J. Harry L. A., P. Lampertico
Determinants of esophageal varices bleeding in patients with advanced hepatocellular carcinoma treated with sorafenib
2016 M. Iavarone, M. Primignani, S. Vavassori, A. Sangiovanni, V. La Mura, R. Romeo, M. Colombo
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
2016 G. Papatheodoridis, G. Dalekos, V. Sypsa, C. Yurdaydin, M. Buti, J. Goulis, J.L. Calleja, H. Chi, S. Manolakopoulos, G. Mangia, N. Gatselis, O. Keskin, S. Savvidou, J. De La Revilla, B.E. Hansen, I. Vlachogiannakos, K. Galanis, R. Idilman, M. Colombo, R. Esteban, H.L.A. Janssen, P. Lampertico
DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection
2016 M.A. Burza, B.M. Motta, R.M. Mancina, P. Pingitore, C. Pirazzi, S.M. Lepore, R. Spagnuolo, P. Doldo, C. Russo, V. Lazzaro, J. Fischer, T. Berg, A. Aghemo, C. Cheroni, R. De Francesco, S. Fargion, M. Colombo, C. Datz, F. Stickel, L. Valenti, S. Romeo
Resistance to thrombomodulin is associated with de novo portal vein thrombosis and low survival in patients with cirrhosis
2016 V. La Mura, A. Tripodi, G. Tosetti, F. Cavallaro, V. Chantarangkul, M. Colombo, M. Primignani
Deciding on interferon-free treatment for chronic hepatitis C : Updating liver stiffness cut-off values to maximize benefit
2016 A. Colli, M. Fraquelli, D. Prati, A. Riva, A. Berzuini, D. Conte, A. Aghemo, M. Colombo, G. Casazza
Liver stiffness measurement reliability and main determinants of point shear-wave elastography in patients with chronic liver disease
2016 M. Fraquelli, A. Baccarin, G. Casazza, C.B. Conti, M. Giunta, S. Massironi, F. Invernizzi, M.F. Donato, M. Maggioni, A. Aghemo, D. Conte, M. Colombo
Serological tests do not predict residual fibrosis in hepatitis C cirrhotics with a sustained virological response to interferon
2016 R. D'Ambrosio, E. Degasperi, A. Aghemo, M. Fraquelli, P. Lampertico, M.G. Rumi, F. Facchetti, E. Grassi, G. Casazza, W. Rosenberg, P. Bedossa, M. Colombo
Challenges in treating patients with inflammatory bowel disease and concurrent viral hepatitis infection
2016 E. Degasperi, F. Caprioli, O. El Sherif, D. Back, M. Colombo, A. Aghemo
A cell culture system for distinguishing hepatitis C viruses with and without liver cancer-related mutations in the viral core gene
2015 A. El Shamy, F.J. Eng, E.H. Doyle, A.L. Klepper, X. Sun, A. Sangiovanni, M. Iavarone, M. Colombo, R.E. Schwartz, Y. Hoshida, A.D. Branch
Extended survival of patients with persistently suppressed hepatitis B transplanted for hepatocellular carcinoma
2015 M. Viganò, S. Bhoori, P. Lampertico, M.F. Donato, M. Iavarone, G. Grossi, A. Facciorusso, L. Caccamo, G. Rossi, M. Colombo, V. Mazzaferro
Cholangiocarcinoma in Cirrhosis : Value of Hepatocyte Specific Magnetic Resonance Imaging
2015 F. Piscaglia, M. Iavarone, M. Galassi, S. Vavassori, M. Renzulli, L.V. Forzenigo, A. Granito, V. Salvatore, A. Sangiovanni, R. Golfieri, M. Colombo, L. Bolondi
Final results of the telaprevir access program : fibroscan values predict safety and efficacy in hepatitis c patients with advanced fibrosis or cirrhosis
2015 A. Lepida, M. Colombo, I. Fernandez, D. Abdurakhmanov, P.A. Ferreira, S.I. Strasser, P. Urbanek, A. Mangia, J.L. Calleja, W. Iraqi, R. Demasi, I. Lonjon Domanec, C. Moreno, H. Wedemeyer